Cognetivity Neurosciences Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

0.27

EPS

—

Div Yield, %

—

Shrs. gr., 5y

18.88%

Rev. gr., 5y

Revenues

45k

Net income

-7m

L-43.37%

CFO

-6m

L+84.86%

Profile

Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

URL

https://www.cognetivity.com/

IPO date

Mar 19, 2018

Employees

2,500

Domiciled in

Incorporated in

Valuation

Order:

Title CAD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY
Title CAD in thousands, except ratios and share amounts	2023‑01	2022‑01	2021‑01	2020‑01	2019‑01	2018‑01	2017‑01	2016‑01
Income
Revenues	45
Cost of revenue	8,391
Unusual Expense (Income)
NOPBT	(8,346)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT	(8,346)
Net income	(7,434) -43.37%
Dividends
Dividend yield
Proceeds from repurchase of equity	2,633
BB yield
Debt
Debt current	2,533
Long-term debt
Deferred revenue
Other long-term liabilities	2,125
Net debt	289
Cash flow
Cash from operating activities	(5,942)
CAPEX	(23)
Cash from investing activities	(70)
Cash from financing activities	6,879
FCF	(3,873)
Balance
Cash	2,244
Long term investments
Excess cash	2,242
Stockholders' equity	(4,703)
Invested Capital	(1,771)
ROIC
ROCE	128.91%
EV
Common stock shares outstanding	85,049
Price
Market cap
EV
EBITDA	(8,321)
EV/EBITDA
Interest	1,027
Interest/NOPBT